Abstract
Abstract
Background
Clinical trial participants have a right to be informed throughout the entire process of human subject research. As part of this pillar of research ethics, participants and other stakeholders should be made aware of research findings after a trial has been completed. Though participants have both a right, and a desire to be informed of research outcomes, studies show that they rarely receive communication about study findings. Our aim was (1) to understand what, if any, role communication plans play in current global health clinical research protocols and (2) to use our findings to develop a communication plan template tailored to clinical research carried out in low-and-middle-income countries (LMIC) while minimizing colonial assumptions. While the template was drafted in the LMIC context, the principles are universally applicable and should be considered best practices for all global health clinical trials.
Methods
We carried out a mixed-method study over a period of 6 months to understand the role of communication with study participants and other stakeholders in clinical trials. The semiquantitative analysis included mining publicly available clinical trial protocols for communication-related language. Qualitative interviews (n = 7) were used to gather knowledge and insight from clinical trial experts to inform the development of a communication plan template.
Results
None of the 48 mined clinical trial protocols included a communication plan. Of the 48, 21% (n = 21) protocols included communication-related language, and 10% (n = 5) described plans to share trial results with participants.
Conclusion
The use of communication plans in global health clinical trials is lacking. To our knowledge, this is the first in-depth analysis of communication plans in clinical trials to date. We recommend that researchers utilize the developed communication plan template throughout the entire research process to ensure a human-centered approach to participant communication. This communication plan should apply to all phases of a research trial, with a particular emphasis on plans to share results in an accessible and engaging manner once the trial has been completed.
Funder
Bill and Melinda Gates Foundation
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Medicine (miscellaneous)
Reference23 articles.
1. McDavitt B, Bogart LM, Mutchler MG, Wagner GJ, Green HD Jr, Lawrence SJ, et al. Dissemination as dialogue: building trust and sharing research findings through community engagement. Prev Chronic Dis. 2016;13:E38.
2. NIH. Respect for potential and enrolled subjects. National Institutes of Health. 2016. https://www.nih.gov/health-information/nih-clinical-research-trials-you/respect-potential-enrolled-subjects.
3. Melvin CL, Harvey J, Pittman T, Gentilin S, Burshell D, Kelechi T. Communicating and disseminating research findings to study participants: formative assessment of participant and researcher expectations and preferences. J Clin Transl Sci. 2020;4(3):233–42.
4. Medicine Io. Public engagement and clinical trials: new models and disruptive technologies: Workshop Summary. Weisfeld V, English RA, Claiborne AB, editors. Washington, DC: The National Academies Press; 2012. 140
5. Long CR, Stewart MK, McElfish PA. Health research participants are not receiving research results: a collaborative solution is needed. Trials. 2017;18(1):449.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献